Complete Filing Data
Evofem Biosciences, Inc. reported Net Income Loss of -$8.86 million for FY2024.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Evofem Biosciences, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $19.4M | $18.2M | $16.8M | $8.2M | $446.0K | $0.00 | ||||||
| Net Income Loss | -$8.9M | $53.0M | -$76.7M | -$205.2M | -$142.3M | -$80.0M | -$125.7M | -$105.3M | -$13.0M | -$43.2M | -$10.8M | -$15.0M |
| Operating Income Loss | -$7.7M | -$17.8M | -$84.1M | -$166.8M | -$103.6M | -$52.7M | -$77.6M | -$35.7M | -$12.0M | -$42.0M | -$9.6M | -$14.4M |
| General And Administrative Expense | $11.6M | $15.0M | $27.6M | $24.7M | $30.1M | $20.3M | $34.2M | $12.1M | $5.5M | $7.6M | $4.4M | $3.0M |
| Research And Development Expense | $1.8M | $2.9M | $25.0M | $33.1M | $17.1M | $22.2M | $43.4M | $23.5M | $6.6M | $34.4M | $5.2M | $11.4M |
| Nonoperating Income Expense | -$1.2M | $70.8M | $7.5M | -$38.4M | -$38.7M | -$27.3M | -$48.1M | -$69.6M | ||||
| Operating Expenses | $104.1M | $52.7M | $77.6M | $35.7M | $12.0M | $42.0M | $9.6M | $14.4M | ||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$8.9M | $53.0M | -$76.7M | -$205.2M | -$142.3M | -$80.0M | -$125.7M | -$105.3M | ||||
| Net Income Loss Available To Common Stockholders Basic | -$9.0M | $50.0M | -$78.0M | -$206.2M | -$142.3M | -$80.0M | -$125.8M | -$109.3M | ||||
| Income Tax Expense Benefit | $17.0K | $44.0K | $17.0K | $4.0K | $4.0K | $2.0K | $3.0K | |||||
| Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment | -$1.9M | $22.8M | $44.4M | $5.1M | $0.00 | |||||||
| Selling And Marketing Expense | $9.2M | $11.7M | $44.0M | $113.2M | $56.5M | $10.2M | ||||||
| Other Nonoperating Income Expense | -$2.1M | -$4.7M | -$2.1M | $301.0K | -$145.0K | -$46.0K | -$47.3K | |||||
| Cost Of Goods And Services Sold | $3.8M | $6.5M | $4.4M | $4.1M | $468.0K | $0.00 | ||||||
| Comprehensive Income Net Of Tax | -$10.6M | $2.6M | -$32.3M | -$200.1M | -$142.3M | |||||||
| Interest Expense | $2.2M | $2.3M | $2.2M | $2.7M | $2.1M | $0.00 | ||||||
| Lease Cost | $1.0M | $1.4M | $879.0K | $642.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue * | $5.0M | $4.8M | $845.0K | $4.5M | $4.2M | $3.6M | $5.1M | $2.5M | $5.8M | $6.4M | $6.0M | $4.3M | $1.7M | $1.9M | $1.1M | $278.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Net Income Loss | -$1.6M | -$1.8M | $956.0K | -$2.4M | $1.4M | -$4.8M | $66.0M | -$8.6M | -$2.4M | $89.5M | -$126.0M | -$31.9M | -$74.1M | -$33.4M | -$46.2M | -$29.9M | -$52.7M | -$19.1M | -$12.7M | -$13.8M | -$35.5M | -$18.1M | -$15.0M | -$18.4M | -$23.2M | -$69.1M | -$19.5M | -$74.0M | -$6.5M | -$5.3M | -$2.4M | -$2.7M | -$6.0M | -$17.3M | -$9.5M | -$6.9M | -$4.0M | -$2.3M | -$1.6M |
| Operating Income Loss | $951.0K | -$1.3M | $327.0K | -$2.4M | -$1.4M | -$2.8M | -$3.6M | -$7.3M | -$3.6M | -$18.7M | -$24.4M | -$28.9M | -$43.4M | -$41.1M | -$44.9M | -$26.2M | -$22.4M | -$19.2M | -$14.3M | -$11.9M | -$13.6M | -$18.4M | -$23.2M | -$21.0M | -$9.1M | -$6.4M | -$4.9M | -$1.9M | -$2.5M | -$5.8M | -$17.0M | -$9.2M | -$6.6M | -$1.9M | -$2.0M | -$2.5M | |||
| General And Administrative Expense | $2.1M | $1.8M | $2.4M | $3.1M | $2.3M | $2.8M | $3.2M | $4.9M | $3.6M | $6.3M | $9.1M | $9.0M | $5.0M | $6.4M | $7.7M | $7.2M | $9.7M | $7.1M | $4.8M | $5.4M | $4.6M | $8.6M | $11.4M | $9.0M | $2.8M | $2.3M | $2.9M | $905.2K | $1.1M | $2.5M | $1.8M | $1.7M | $1.9M | $922.8K | $1.1M | $1.1M | |||
| Research And Development Expense | $332.0K | $270.0K | $594.0K | $614.0K | $402.0K | $540.0K | $5.2M | $7.7M | $10.4M | $8.7M | $8.5M | $7.3M | $4.2M | $2.6M | $4.2M | $5.7M | $5.2M | $7.9M | $9.9M | $11.8M | $12.0M | $6.3M | $4.1M | $2.0M | $964.9K | $1.4M | $3.3M | $15.2M | $7.5M | $4.7M | $942.7K | $932.1K | $1.4M | ||||||
| Nonoperating Income Expense | -$2.5M | -$526.0K | $629.0K | $67.0K | $2.7M | -$2.0M | $69.6M | -$1.2M | $1.2M | $108.2M | -$101.5M | -$3.0M | -$30.7M | $7.7M | -$1.3M | -$3.7M | -$30.3M | $98.0K | $155.0K | $499.0K | -$23.5M | -$4.4M | $0.00 | $2.0K | $0.00 | -$48.1M | $4.1M | $65.0M | $154.0K | $353.0K | |||||||||
| Operating Expenses | $45.1M | $43.0M | $46.0M | $26.4M | $22.4M | $19.2M | $12.9M | $14.3M | $11.9M | $13.6M | $15.0M | $18.4M | $23.2M | $21.0M | $15.3M | $9.1M | $6.4M | $4.9M | $1.9M | $2.5M | $5.8M | $17.0M | $9.2M | $6.6M | $1.9M | $2.0M | $2.5M | ||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$1.6M | -$1.8M | $956.0K | -$2.4M | $1.4M | -$4.8M | $66.0M | -$8.6M | -$2.4M | $89.5M | -$126.0M | -$31.9M | -$74.1M | -$33.4M | -$46.2M | -$29.9M | -$52.7M | -$19.1M | -$13.8M | -$35.4M | -$18.1M | -$18.4M | -$23.2M | -$69.1M | -$74.0M | -$6.5M | -$5.3M | ||||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$1.7M | -$1.8M | $953.0K | -$2.4M | $1.3M | -$4.9M | $66.0M | -$8.6M | -$2.4M | $89.5M | -$124.1M | -$32.0M | -$74.1M | -$33.4M | -$46.2M | -$12.7M | -$13.8M | -$35.5M | -$18.1M | -$15.0M | -$18.4M | -$23.2M | -$69.1M | -$20.7M | -$75.1M | -$7.4M | -$6.2M | ||||||||||||
| Income Tax Expense Benefit | -$4.0K | $7.0K | -$8.0K | $8.0K | $11.0K | $3.0K | $3.0K | $13.0K | $20.0K | $3.0K | $0.00 | $12.0K | -$1.0K | $2.0K | $0.00 | $0.00 | $0.00 | $4.0K | $0.00 | $0.00 | $2.0K | $0.00 | $0.00 | $0.00 | $3.0K | ||||||||||||||
| Other Comprehensive Income Loss Financial Liability Fair Value Option After Tax And Reclassification Adjustment | -$4.2M | -$573.0K | $647.0K | -$1.1M | -$256.0K | $324.0K | -$455.0K | $8.4M | $15.5M | $35.4M | -$3.7M | $181.0K | $5.1M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||
| Selling And Marketing Expense | $2.4M | $2.6M | $2.6M | $2.4M | $2.2M | $2.3M | $3.0M | $2.2M | $3.9M | $11.9M | $12.3M | $12.7M | $30.5M | $27.2M | $30.5M | $14.7M | $10.0M | $7.9M | $3.8M | $1.3M | $1.1M | ||||||||||||||||||
| Other Nonoperating Income Expense | -$596.0K | -$1.1M | -$318.0K | -$436.0K | -$415.0K | -$471.0K | -$1.2M | -$1.2M | -$1.1M | -$657.0K | -$349.0K | -$4.0K | $287.0K | -$7.0K | -$14.0K | -$33.0K | -$32.0K | -$50.0K | -$42.0K | $64.0K | -$34.0K | ||||||||||||||||||
| Cost Of Goods And Services Sold | $905.0K | $755.0K | $365.0K | $869.0K | $769.0K | $684.0K | $1.9M | $2.3M | $1.4M | $1.7M | $1.3M | $1.1M | $955.0K | $839.0K | $506.0K | $317.0K | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||
| Comprehensive Income Net Of Tax | -$5.7M | -$2.4M | $1.6M | -$3.3M | $1.1M | -$4.5M | -$7.6M | -$190.0K | $13.1M | $124.9M | -$129.7M | -$31.7M | -$69.0M | -$33.4M | -$46.2M | -$29.9M | |||||||||||||||||||||||
| Interest Expense | $577.0K | $564.0K | $565.0K | $523.0K | $1.2M | $0.00 | |||||||||||||||||||||||||||||||||
| Lease Cost | $504.0K | $395.0K | $330.0K | $164.0K | $157.0K | $0.00 |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$71.8M | -$104.3M | $1.3M | $15.6M | -$23.4M | -$289.5M | -$181.1M | $23.8M | $65.2M | -$56.7M | -$41.8M | ||
| Cash And Cash Equivalents At Carrying Value | $2.8M | $7.7M | $48.9M | $15.6M | $1.3M | $1.2M | $11.5M | $37.7M | $75.9M | $4.4M | $11.1M | ||
| Retained Earnings Accumulated Deficit | -$888.7M | -$938.7M | -$860.7M | -$655.5M | -$513.2M | -$433.1M | -$307.3M | -$125.9M | -$112.8M | -$69.7M | |||
| Prepaid Expense And Other Assets Current | $1.2M | $2.2M | $3.2M | $18.1M | $2.3M | $717.0K | $653.0K | $1.0M | $2.0M | $925.8K | |||
| Liabilities Current | $72.5M | $93.8M | $137.7M | $77.3M | $12.7M | $27.3M | $103.3M | $902.2K | $9.1M | $1.9M | |||
| Liabilities And Stockholders Equity | $10.6M | $25.2M | $42.5M | $110.0M | $28.3M | $4.0M | $4.0M | $12.8M | $40.1M | $76.9M | |||
| Assets Current | $9.2M | $12.7M | $30.1M | $97.7M | $26.4M | $2.5M | $2.4M | $12.5M | $39.7M | $76.9M | |||
| Assets | $10.6M | $25.2M | $42.5M | $110.0M | $28.3M | $4.0M | $4.0M | $12.8M | $40.1M | $76.9M | |||
| Accounts Payable Current | $17.0M | $15.0M | $10.3M | $10.6M | $6.0M | $8.9M | $9.0M | $503.7K | $4.0M | $997.3K | |||
| Property Plant And Equipment Net | $1.2M | $3.9M | $5.8M | $4.3M | $394.0K | $593.0K | $848.0K | $109.3K | $186.4K | $24.8K | |||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $4.8M | $13.6M | $72.3M | $16.6M | $1.8M | $1.7M | $11.7M | $37.9M | $75.9M | ||||
| Restricted Cash Current | $580.0K | $1.2M | $5.1M | $22.6M | $304.0K | $431.0K | $490.0K | ||||||
| Common Stock Value | $2.0K | $12.0K | $16.0K | $8.0K | $5.0K | $3.0K | $0.00 | $230.00 | $1.4K | $1.4K | |||
| Accrued Liabilities Current | $4.2M | $4.1M | $8.4M | $4.5M | $2.8M | $11.5M | $12.1M | $398.5K | |||||
| Additional Paid In Capital Common Stock | $751.3M | $656.8M | $528.8M | $409.8M | $17.7M | $137.8M | $136.6M | $134.9M | |||||
| Other Assets Noncurrent | $35.0K | $4.1M | $1.2M | $1.0M | $1.3M | $939.0K | $750.0K | ||||||
| Liabilities | $72.5M | $97.0M | $142.1M | $108.6M | $12.7M | $27.4M | $103.6M | ||||||
| Employee Related Liabilities Current | $2.6M | $2.2M | $4.7M | $6.5M | $3.7M | $2.9M | $2.4M | ||||||
| Operating Lease Right Of Use Asset | $106.0K | $4.4M | $5.4M | $6.9M | $160.0K | ||||||||
| Operating Lease Liability Current | $97.0K | $2.3M | $2.3M | $2.3M | $197.0K | ||||||||
| Operating Lease Liability Noncurrent | $8.0K | $3.1M | $4.4M | $6.0M | $0.00 | ||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $161.0K | -$4.2M | -$8.8M | -$58.7M | $55.6M | $14.9M | $60.0K | ||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $11.5M | ||||||||||||
| Accounts Receivable Net Current | $5.7M | $1.1M | $6.4M | $1.1M | $0.00 | ||||||||
| Other Liabilities Current | $3.3M | $2.9M | $2.9M | $953.0K | $0.00 | ||||||||
| Derivative Liabilities Current | $1.9M | $1.7M | $202.0K | $0.00 | $0.00 | $79.9M | |||||||
| Inventory Net | $1.7M | $5.4M | $7.7M | $7.2M | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | -$75.1M | -$69.6M | -$69.6M | -$71.3M | -$70.9M | -$69.3M | -$70.7M | -$66.5M | -$56.4M | -$55.7M | -$56.4M | -$78.0M | -$216.0M | -$128.1M | -$58.8M | $9.0M | -$13.6M | $40.2M | $68.5M | $1.0M | $24.1M | $35.8M | -$28.9M | -$10.1M | $5.3M | -$18.3M | $4.8M | $6.5M | $9.0M | $13.8M | $16.0M | $18.5M | $32.7M | $49.6M | $58.6M | ||||||||
| Cash And Cash Equivalents At Carrying Value | $221.0K | $639.0K | $7.7M | $19.9M | $2.8M | $14.9M | $47.0M | $45.3M | $86.7M | $123.6M | $8.8M | $32.1M | $50.7M | $184.0K | $12.1M | $22.8M | $5.0M | $3.7M | $1.0M | $4.6M | $14.4M | $21.5M | $24.1M | $51.3M | $63.0M | $70.7M | $14.7M | $11.5M | $9.5M | ||||||||||||||
| Retained Earnings Accumulated Deficit | -$900.2M | -$898.5M | -$896.7M | -$897.7M | -$894.6M | -$892.3M | -$893.6M | -$884.6M | -$949.6M | -$941.0M | -$930.4M | -$1.02B | -$892.6M | -$809.1M | -$735.1M | -$701.6M | -$614.9M | -$585.0M | -$532.3M | -$500.5M | -$486.7M | -$451.2M | -$418.2M | -$399.7M | -$376.5M | -$133.5M | -$131.7M | -$128.9M | -$123.9M | -$121.5M | -$118.9M | -$103.3M | -$86.1M | -$76.6M | |||||||||
| Prepaid Expense And Other Assets Current | $959.0K | $1.4M | $1.4M | $1.5M | $999.0K | $845.0K | $622.0K | $2.2M | $2.5M | $2.1M | $4.8M | $7.2M | $4.6M | $16.7M | $19.8M | $4.1M | $10.6M | $2.7M | $3.0M | $1.3M | $1.8M | $813.0K | $902.0K | $1.1M | $1.6M | $380.0K | $502.1K | $853.6K | $509.4K | $757.7K | $1.1M | $995.9K | $815.5K | $761.6K | |||||||||
| Liabilities Current | $78.2M | $73.9M | $70.9M | $80.4M | $76.3M | $73.2M | $74.2M | $67.9M | $69.7M | $79.8M | $116.7M | $265.6M | $154.5M | $94.7M | $68.3M | $75.7M | $65.7M | $61.8M | $14.5M | $14.9M | $18.6M | $32.1M | $25.0M | $20.8M | $27.0M | $1.4M | $1.7M | $1.7M | $1.4M | $3.7M | $3.9M | $12.0M | $6.0M | $4.0M | |||||||||
| Liabilities And Stockholders Equity | $13.8M | $14.4M | $12.9M | $23.8M | $23.9M | $8.6M | $8.2M | $13.3M | $14.1M | $26.0M | $42.3M | $53.5M | $34.6M | $67.4M | $108.7M | $93.5M | $112.3M | $135.1M | $15.6M | $39.0M | $54.4M | $3.2M | $15.0M | $26.2M | $9.0M | $6.2M | $8.2M | $10.7M | $15.2M | $22.6M | $25.5M | $52.7M | $64.2M | $71.9M | |||||||||
| Assets Current | $7.9M | $9.0M | $5.9M | $13.6M | $8.6M | $7.2M | $6.9M | $11.5M | $12.0M | $16.5M | $31.8M | $41.9M | $21.4M | $54.9M | $95.6M | $80.3M | $102.1M | $127.9M | $13.7M | $37.5M | $52.8M | $1.4M | $13.4M | $24.5M | $7.2M | $6.1M | $8.1M | $10.6M | $14.9M | $22.2M | $25.2M | $52.3M | $63.8M | $71.5M | |||||||||
| Assets | $13.8M | $14.4M | $12.9M | $23.8M | $23.9M | $8.6M | $8.2M | $13.3M | $14.1M | $26.0M | $42.3M | $53.5M | $34.6M | $67.4M | $108.7M | $93.5M | $112.3M | $135.1M | $15.6M | $39.0M | $54.4M | $3.2M | $15.0M | $26.2M | $9.0M | $6.2M | $8.2M | $10.7M | $15.2M | $22.6M | $25.5M | $52.7M | $64.2M | $71.9M | |||||||||
| Accounts Payable Current | $11.6M | $12.3M | $11.2M | $16.2M | $16.9M | $16.0M | $16.3M | $16.2M | $17.2M | $18.8M | $14.5M | $15.4M | $14.0M | $6.8M | $7.7M | $6.5M | $5.4M | $8.4M | $7.1M | $5.2M | $8.6M | $11.9M | $8.0M | $8.0M | $13.3M | $410.2K | $549.0K | $955.3K | $797.2K | $1.1M | $1.4M | $6.4M | $3.0M | $1.9M | |||||||||
| Property Plant And Equipment Net | $420.0K | $424.0K | $429.0K | $458.0K | $1.2M | $1.2M | $1.2M | $1.6M | $1.7M | $3.7M | $4.3M | $5.3M | $5.5M | $5.8M | $6.0M | $5.6M | $2.0M | $1.1M | $622.0K | $546.0K | $461.0K | $527.0K | $652.0K | $717.0K | $783.0K | $22.5K | $29.5K | $36.5K | $132.5K | $150.9K | $168.6K | $204.1K | $221.9K | $241.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $840.0K | $748.0K | $1.1M | $741.0K | $722.0K | $692.0K | $689.0K | $580.0K | $410.0K | $636.0K | $1.5M | $9.8M | $22.3M | $7.7M | $25.0M | $63.0M | $65.1M | $87.8M | $124.6M | $10.0M | $32.5M | $51.1M | $600.0K | $5.8M | $14.6M | ||||||||||||||||||
| Restricted Cash Current | $840.0K | $748.0K | $888.0K | $741.0K | $722.0K | $692.0K | $689.0K | $410.0K | $636.0K | $895.0K | $1.3M | $1.6M | $4.2M | $9.4M | $15.2M | $19.0M | $337.0K | $200.0K | $480.0K | $386.0K | $401.0K | $416.0K | $446.0K | $554.0K | $569.0K | ||||||||||||||||||
| Common Stock Value | $12.0K | $12.0K | $11.0K | $11.0K | $10.0K | $8.0K | $5.0K | $10.0K | $8.0K | $1.0K | $16.0K | $16.0K | $10.0K | $8.0K | $8.0K | $5.0K | $5.0K | $5.0K | $3.0K | $3.0K | $3.0K | $2.0K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | $1.4K | ||||||||||||
| Accrued Liabilities Current | $1.4M | $3.3M | $3.2M | $5.5M | $5.1M | $4.8M | $4.6M | $5.1M | $4.2M | $3.5M | $5.5M | $6.9M | $9.7M | $9.0M | $7.5M | $9.0M | $4.6M | $2.6M | $2.5M | $6.5M | $7.2M | $11.6M | $14.4M | $11.1M | $12.6M | $3.6M | $1.8M | $1.6M | $912.3K | ||||||||||||||
| Additional Paid In Capital Common Stock | $819.7M | $817.4M | $815.3M | $802.3M | $759.2M | $745.2M | $744.0M | $688.0M | $655.1M | $653.5M | $533.3M | $524.5M | $522.5M | $422.4M | $408.1M | $405.0M | $358.2M | $138.3M | $138.2M | $137.9M | $137.7M | $137.6M | $137.4M | $136.0M | $135.6M | $135.2M | |||||||||||||||||
| Other Assets Noncurrent | $36.0K | $36.0K | $36.0K | $36.0K | $36.0K | $36.0K | $35.0K | $35.0K | $195.0K | $1.9M | $1.1M | $1.2M | $2.7M | $991.0K | $1.0M | $1.0M | $1.1M | $1.1M | $1.0M | $596.0K | $622.0K | $649.0K | $950.0K | $977.0K | $1.0M | ||||||||||||||||||
| Liabilities | $84.0M | $79.2M | $77.7M | $90.3M | $90.1M | $73.2M | $74.2M | $67.9M | $69.7M | $82.4M | $120.3M | $269.5M | $158.5M | $126.3M | $99.8M | $107.1M | $72.1M | $66.5M | $14.6M | $14.9M | $18.6M | $32.1M | $25.1M | $20.9M | $27.3M | ||||||||||||||||||
| Employee Related Liabilities Current | $3.6M | $3.2M | $2.6M | $3.5M | $3.2M | $3.3M | $3.3M | $1.8M | $1.6M | $1.4M | $4.8M | $5.5M | $5.1M | $5.3M | $4.3M | $3.0M | $5.0M | $5.9M | $4.7M | $2.9M | $2.3M | $3.7M | $2.6M | $1.7M | $1.1M | ||||||||||||||||||
| Operating Lease Right Of Use Asset | $195.0K | $214.0K | $52.0K | $89.0K | $127.0K | $114.0K | $59.0K | $151.0K | $3.3M | $5.1M | $5.0M | $5.0M | $5.8M | $6.1M | $6.5M | $7.2M | $5.0M | $262.0K | $315.0K | $483.0K | $645.0K | $0.00 | |||||||||||||||||||||
| Operating Lease Liability Current | $124.0K | $124.0K | $48.0K | $82.0K | $116.0K | $113.0K | $55.0K | $138.0K | $173.0K | $2.2M | $2.6M | $2.3M | $2.2M | $2.4M | $2.5M | $2.5M | $1.7M | $542.0K | $103.0K | $382.0K | $580.0K | $772.0K | $0.00 | ||||||||||||||||||||
| Operating Lease Liability Noncurrent | $72.0K | $89.0K | $5.0K | $7.0K | $10.0K | $1.0K | $4.0K | $13.0K | $4.2M | $3.6M | $3.9M | $4.1M | $4.8M | $5.2M | $5.6M | $6.4M | $4.7M | $163.0K | |||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $368.0K | $109.0K | -$3.2M | -$5.9M | -$7.2M | -$6.6M | -$1.2M | ||||||||||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $410.0K | $636.0K | $1.5M | $4.8M | $9.8M | $22.3M | $7.7M | $13.6M | $32.5M | $51.1M | $600.0K | $1.8M | $12.5M | $23.3M | $5.6M | $1.7M | $4.2M | $1.5M | $5.1M | ||||||||||||||||||||||||
| Accounts Receivable Net Current | $4.4M | $4.9M | $1.1M | $9.8M | $5.4M | $4.6M | $4.3M | $6.3M | $5.2M | $7.4M | $12.8M | $7.3M | $4.4M | $4.0M | $3.1M | $2.9M | $1.2M | ||||||||||||||||||||||||||
| Other Liabilities Current | $8.2M | $7.6M | $7.2M | $7.4M | $3.8M | $3.4M | $3.5M | $3.6M | $3.2M | $5.1M | $2.4M | $1.4M | $2.5M | $2.1M | $1.5M | $921.0K | |||||||||||||||||||||||||||
| Derivative Liabilities Current | $1.1M | $3.0K | $138.0K | $1.4M | $162.0K | $942.0K | $4.3M | $122.0K | $6.6M | $113.5M | $7.8M | $0.00 | $0.00 | $0.00 | |||||||||||||||||||||||||||||
| Inventory Net | $1.7M | $1.9M | $2.3M | $1.6M | $1.5M | $1.1M | $1.3M | $2.5M | $3.7M | $5.5M | $9.9M | $10.5M | $9.0M | $3.2M | $1.4M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $4.6M | $4.8M | $61.9M | $90.7M | $154.2M | $78.1M | $54.4M | $9.2M | -$10.0M | $138.6K | $81.2M | $6.1M |
| Investing Cash Flow * | -$569.0K | -$4.0K | -$341.0K | -$2.7M | $6.2M | -$8.1M | $2.1M | $244.0K | $3.1K | -$226.1K | -$18.1K | $83.0K |
| Operating Cash Flow * | -$3.9M | -$9.0M | -$70.4M | -$146.7M | -$104.8M | -$55.1M | -$56.5M | -$19.2M | -$16.3M | -$37.9M | -$9.6M | -$12.9M |
| Share Based Compensation | $847.0K | $1.2M | $3.3M | $8.9M | $12.7M | $8.6M | $17.8M | $861.0K | $1.1M | $1.6M | $613.0K | $80.5K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $265.0K | -$3.7M | -$2.6M | -$13.9M | $17.4M | $952.0K | $11.0K | -$145.0K | -$947.5K | $1.1M | $783.9K | -$1.3M |
| Payments To Acquire Property Plant And Equipment | $14.0K | $4.0K | $341.0K | $2.9M | $2.3M | $164.0K | $7.0K | $6.0K | $226.1K | $18.1K | $21.2K | |
| Increase Decrease In Employee Related Liabilities | $885.0K | $434.0K | -$2.5M | -$1.9M | $2.8M | $746.0K | $307.0K | $775.0K | ||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $5.3M | $527.0K | -$4.1M | $5.5M | $2.7M | -$8.8M | -$795.0K | $7.3M | ||||
| Increase Decrease In Accounts Payable | -$910.0K | $4.1M | $4.5M | -$4.0K | $4.1M | -$2.9M | $3.8M | $7.1M | ||||
| Increase Decrease In Inventories | -$57.0K | -$2.1M | -$1.6M | $21.0K | $6.0M | $0.00 | ||||||
| Increase Decrease In Accounts Receivable | $4.1M | $4.6M | -$5.3M | $5.4M | $1.1M | $0.00 | ||||||
| Increase Decrease In Operating Lease Liabilities | -$1.5M | -$1.4M | $1.5M | $493.0K | $761.0K | $0.00 | ||||||
| Proceeds From Warrant Exercises | $290.0K | $25.2M | $159.0K | $2.0K | $6.3M | $0.00 | ||||||
| Proceeds From Issuance Of Long Term Debt | $5.6M | $11.5M | $0.00 | $50.0M | $0.00 | $10.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q2 2023 | Q1 2023 | Q2 2022 | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | -$135.0K | $1.7M | $15.1M | $28.0M | $1.4M | $6.3M | $19.9M | -$580.0K | -$6.1M | $7.9M | ||||
| Investing Cash Flow * | -$57.0K | -$14.0K | -$3.0K | -$66.0K | -$706.0K | $6.9M | $250.0K | $2.2M | $250.0K | -$426.1K | -$2.6K | |||
| Operating Cash Flow * | $560.0K | $123.0K | -$4.9M | -$20.9M | -$34.5M | -$14.9M | -$7.7M | -$18.1M | -$6.1M | -$7.6M | -$4.8M | -$2.8M | ||
| Share Based Compensation | $70.0K | $237.0K | $268.0K | $417.0K | $1.1M | $1.1M | $3.5M | $3.4M | $2.0M | $688.0K | $219.0K | $714.7K | $299.1K | $98.1K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$107.0K | -$573.0K | -$1.5M | $1.0M | -$13.6M | $1.0M | -$12.0K | $574.0K | $95.0K | -$901.7K | -$164.2K | -$12.4K | ||
| Payments To Acquire Property Plant And Equipment | $14.0K | $3.0K | $66.0K | $956.0K | $95.0K | $226.1K | $2.6K | |||||||
| Increase Decrease In Employee Related Liabilities | -$849.0K | $652.0K | -$800.0K | $469.0K | -$3.5M | $1.1M | $800.0K | -$1.5M | -$469.0K | |||||
| Increase Decrease In Accrued Liabilities And Other Operating Liabilities | $34.0K | $438.0K | -$352.0K | -$85.0K | $4.7M | -$205.0K | $252.0K | $390.0K | -$1.7M | |||||
| Increase Decrease In Accounts Payable | -$1.8M | -$726.0K | $3.8M | $3.7M | -$4.6M | $996.0K | $2.9M | $4.0M | $805.0K | |||||
| Increase Decrease In Inventories | $864.0K | -$391.0K | $99.0K | -$755.0K | $1.7M | $0.00 | ||||||||
| Increase Decrease In Accounts Receivable | -$8.7M | -$1.4M | $6.3M | -$2.0M | $1.8M | $0.00 | ||||||||
| Increase Decrease In Operating Lease Liabilities | $591.0K | $466.0K | -$229.0K | $197.0K | $186.0K | $0.00 | ||||||||
| Proceeds From Warrant Exercises | $61.0K | $0.00 | $6.3M | |||||||||||
| Proceeds From Issuance Of Long Term Debt | $1.6M | $10.0M | $0.00 |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.12 | $0.05 | -$167.42 | -$23.63 | -$2.12 | -$1.99 | -$5.74 | -$55.78 | -$5.66 | -$18.91 | -$5.36 | -$29.33 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Authorized | 3.00B | 3.00B | 500.0M | 500.0M | 300.0M | 4.1M | 300.0M | 300.0M | 300.0M | |||
| Common Stock Shares Outstanding | 20.0M | 984.8K | 10.8M | 81.4M | 48.1M | 25.9M | 2.1M | 2.3M | 13.8M | 13.7M | ||
| Common Stock Shares Issued | 20.0M | 984.8K | 10.8M | 81.4M | 48.1M | 25.9M | 2.1M | 2.3M | 13.8M | 13.7M | ||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 67.2M | 40.2M | 21.9M | 2.0M | 2.3M | 2.3M | 2.0M | 511.9K | ||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Weighted Average Number Of Shares Outstanding Basic | 75.2M | 4.8M | 466.0K | 8.7M | 67.2M | |||||||
| Earnings Per Share Basic | $-0.12 | $10.36 | $-167.42 | $-23.63 | $-2.12 | |||||||
| Weighted Average Number Of Diluted Shares Outstanding | 75.2M | 984.0M | 466.0K | 8.7M | 67.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q4 2019 | Q3 2019 | Q2 2019 | Q1 2019 | Q4 2018 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.01 | -$0.02 | $0.00 | -$0.02 | $0.00 | -$0.16 | $0.10 | -$5.43 | -$1.85 | -$4.39 | -$580.48 | -$2.88 | -$7.20 | -$4.01 | -$8.46 | -$0.37 | -$0.91 | -$0.40 | -$0.27 | -$0.30 | -$0.97 | -$0.67 | -$0.58 | -$0.71 | -$1.11 | -$4.62 | -$10.55 | -$38.31 | -$3.78 | -$3.14 | -$0.17 | -$0.19 | -$0.44 | -$1.26 | -$0.69 | -$0.50 | -$7.31 | -$4.13 | -$3.00 | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |||||||
| Common Stock Shares Authorized | 3.00B | 3.00B | 3.00B | 3.00B | 3.00B | 3.00B | 3.00B | 3.00B | 500.0M | 500.0M | 500.0M | 500.0M | 500.0M | 3.00B | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | 300.0M | ||||||
| Common Stock Shares Outstanding | 124.0M | 118.7M | 113.4M | 113.4M | 100.3M | 82.8M | 48.7M | 5.7M | 2.5M | 1.7M | 102.0M | 79.1M | 12.3M | 155.2M | 155.1M | 100.3M | 81.3M | 81.3M | 49.6M | 46.8M | 46.4M | 28.7M | 25.9M | 25.2M | 17.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.7M | 13.7M | 13.7M | ||||||||
| Common Stock Shares Issued | 124.0M | 118.7M | 113.4M | 113.4M | 100.3M | 82.8M | 48.7M | 5.7M | 2.5M | 1.7M | 102.0M | 79.1M | 12.3M | 155.2M | 155.1M | 100.3M | 81.3M | 81.3M | 49.6M | 46.8M | 46.4M | 28.7M | 25.9M | 25.2M | 17.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.8M | 13.7M | 13.7M | 13.7M | ||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 81.8M | 81.2M | 57.7M | 48.2M | 46.2M | 36.7M | 26.9M | 25.8M | 20.9M | 15.0M | 2.0M | 2.0M | 2.0M | 13.8M | 13.8M | 13.8M | 13.7M | 13.7M | 13.7M | 552.4K | 552.4K | 533.5K | ||||||||||||||||||||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | 5.0M | |||||||||||||||||||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||||||||||||||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||||||||||||
| Weighted Average Number Of Shares Outstanding Basic | 119.6M | 115.7M | 113.4M | 96.5M | 66.8M | 31.2M | 4.2M | 1.6M | 1.3M | 659.5K | 217.0K | 88.7K | 10.3M | 8.3M | 5.5M | 81.2M | 57.7M | |||||||||||||||||||||||||
| Earnings Per Share Basic | $-0.01 | $-0.02 | $0.01 | $-0.02 | $0.02 | $-0.16 | $15.34 | $-5.43 | $-1.85 | $135.72 | $-580.48 | $-360.25 | $-7.20 | $-4.01 | $-8.46 | $-0.37 | $-0.91 | |||||||||||||||||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 119.6M | 115.7M | 6.04B | 96.5M | 1.61B | 31.2M | 730.0M | 1.6M | 1.3M | 4.4M | 217.0K | 11.1M | 10.3M | 8.3M | 5.5M | 81.2M | 57.7M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $16.0K | $31.0K | $85.0K | $15.0K | $169.0K | $458.0K | $127.0K | $128.0K | $59.5K | $26.0K | $7.6K | $1.3K |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $847.0K | $1.2M | $3.3M | $8.9M | $12.7M | $8.6M | $17.8M | $861.0K | $1.1M | $1.4M | $613.0K | $80.5K |
| Depreciation And Amortization | $477.0K | $1.0M | $1.0M | $302.0K | $263.0K | $262.0K | $244.0K | $69.1K | $58.4K | $17.7K | $72.2K | |
| Fair Value Option Changes In Fair Value Gain Loss1 | $82.5M | -$33.7M | $27.3M | -$27.4M | ||||||||
| Costs And Expenses | $27.0M | $36.1M | $101.0M | $175.0M | $104.1M | |||||||
| Loss On Issuance Of Financial Instruments | $73.0M | $0.00 | $64.0M | $674.0K | ||||||||
| Fair Value Adjustment Of Warrants | -$82.5M | $33.7M | -$27.3M | $27.4M | $0.00 | $860.8K | $490.8K | |||||
| Capital Expenditures Incurred But Not Yet Paid | $105.0K | $476.0K | $823.0K | $10.0K | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $3.0K | $2.0K | $8.0K | $3.0K | $6.0K | $4.0K | $2.0K | $8.0K | $18.0K | $50.0K | $4.0K | $1.0K | $3.0K | $4.0K | $7.0K | $21.0K | $29.0K | $102.0K | $212.0K | $108.0K | $18.0K | $35.0K | $32.0K | $30.0K | $32.0K | $32.0K | $31.0K | $13.9K | $16.4K | $19.7K | $6.0K | $6.9K | $7.5K | $1.2K | $985.00 | $908.00 |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $23.0K | $31.0K | $70.0K | $203.0K | $219.0K | $237.0K | $258.0K | $268.0K | $417.0K | $981.0K | $1.1M | $1.1M | $1.1M | $3.0M | $3.5M | $1.6M | $6.0M | $3.4M | $2.3M | $2.5M | $2.0M | $4.7M | $10.7M | $688.0K | ||||||||||||
| Depreciation And Amortization | $245.0K | $265.0K | $195.0K | $69.0K | $66.0K | $65.0K | $48.0K | $17.8K | $3.8K | $5.0K | ||||||||||||||||||||||||||
| Fair Value Option Changes In Fair Value Gain Loss1 | -$73.0K | $1.6M | $133.1M | -$30.0M | -$1.6M | -$29.5M | $8.9M | -$142.0K | -$3.1M | $34.1M | $0.00 | $0.00 | -$22.9M | |||||||||||||||||||||||
| Costs And Expenses | $4.0M | $6.1M | $518.0K | $6.9M | $5.5M | $6.4M | $8.7M | $9.8M | $9.4M | $25.1M | $30.5M | $33.2M | $45.1M | $43.0M | $46.0M | |||||||||||||||||||||
| Loss On Issuance Of Financial Instruments | $27.0K | $84.0K | $0.00 | $71.2M | $852.0K | $0.00 | $0.00 | $0.00 | $0.00 | $64.0M | $0.00 | $674.0K | ||||||||||||||||||||||||
| Fair Value Adjustment Of Warrants | -$1.6M | $1.6M | $0.00 | $0.00 | $3.3M | $4.4M | $0.00 | $0.00 | $0.00 | $2.0M | $271.3K | -$886.0K | ||||||||||||||||||||||||
| Capital Expenditures Incurred But Not Yet Paid | $140.0K | $57.0K | $519.0K | $201.0K | $0.00 |
Most recent annual filing with the SEC: March 24, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.